TipRanks
Advertisement
Advertisement

DE:978 Stock Latest News

Adagene Announces Finance Executive Resignation Effective September 30, 2026
Company AnnouncementsAdagene Announces Finance Executive Resignation Effective September 30, 2026
10d ago
6K
ADAG
Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138
PremiumCompany Announcements
Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138
14d ago
6K
ADAG
Adagene announces China’s NMPA approved IND for ADG138
PremiumThe Fly
Adagene announces China’s NMPA approved IND for ADG138
14d ago
ADAG
Adagene’s Platform Partnerships and Muzastotug Catalysts Support Buy Rating, Price Target Unchanged at $8
PremiumRatings
Adagene’s Platform Partnerships and Muzastotug Catalysts Support Buy Rating, Price Target Unchanged at $8
26d ago
ADAG
Adagene Deepens Third Arc Bio Partnership as First SAFEbody-Based CD3 Lead Selected
PremiumCompany Announcements
Adagene Deepens Third Arc Bio Partnership as First SAFEbody-Based CD3 Lead Selected
26d ago
6K
ADAG
Adagene initiated with a Buy at Chardan
PremiumThe FlyAdagene initiated with a Buy at Chardan
26d ago
ADAG
Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration
Premium
Company Announcements
Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration
27d ago
6K
ADAG
Adagene announces $2M milestone payment from Exelixis
Premium
The Fly
Adagene announces $2M milestone payment from Exelixis
27d ago
ADAG
EXEL
Adagene Extends Cash Runway and Advances Muzastotug Through Mid-2026 Clinical Milestones
PremiumCompany Announcements
Adagene Extends Cash Runway and Advances Muzastotug Through Mid-2026 Clinical Milestones
2M ago
6K
ADAG
Adagene Discloses Preliminary US$127.9 Million Cash Balance as of June 30, 2026
PremiumCompany Announcements
Adagene Discloses Preliminary US$127.9 Million Cash Balance as of June 30, 2026
3M ago
6K
ADAG
Analyst Initiates Buy on Muza Developer, Citing Promising MSS CRC Data, Clear Registrational Path, and Broader Expansion Upside Despite Cash Constraints
PremiumRatings
Analyst Initiates Buy on Muza Developer, Citing Promising MSS CRC Data, Clear Registrational Path, and Broader Expansion Upside Despite Cash Constraints
5M ago
ADAG
Adagene Showcases Promising Muzastotug Triplet Data at AACR 2026 for Liver and Colorectal Cancers
PremiumCompany Announcements
Adagene Showcases Promising Muzastotug Triplet Data at AACR 2026 for Liver and Colorectal Cancers
6M ago
6K
ADAG
Adagene presents data from two Phase 1b/2 studies of muzastotug at AACR
PremiumThe FlyAdagene presents data from two Phase 1b/2 studies of muzastotug at AACR
6M ago
ADAG
Adagene: Deepening Dose‑Response Evidence and Strategic Partnership Support Buy Rating on Lead CTLA‑4 Program
Premium
Ratings
Adagene: Deepening Dose‑Response Evidence and Strategic Partnership Support Buy Rating on Lead CTLA‑4 Program
6M ago
ADAG
Adagene price target raised to $10 from $9 at Guggenheim
Premium
The Fly
Adagene price target raised to $10 from $9 at Guggenheim
6M ago
ADAG
Adagene 18.666M share Spot Secondary priced at $3.75
PremiumThe Fly
Adagene 18.666M share Spot Secondary priced at $3.75
6M ago
ADAG
Adagene enters pact with Incyte for combination of muzastotug, INCA33890
PremiumThe Fly
Adagene enters pact with Incyte for combination of muzastotug, INCA33890
6M ago
ADAG
Adagene announces results from the latest data cut of muzastotug study
PremiumThe Fly
Adagene announces results from the latest data cut of muzastotug study
6M ago
MRK
ADAG
Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer
PremiumCompany Announcements
Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer
6M ago
6K
ADAG
Adagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline
PremiumCompany AnnouncementsAdagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline
6M ago
6K
ADAG
Adagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 2028
Premium
Company Announcements
Adagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 2028
6M ago
6K
ADAG
Adagene reports FY25 EPS (24c) vs (51c) last year
Premium
The Fly
Adagene reports FY25 EPS (24c) vs (51c) last year
6M ago
ADAG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >